Thursday 28 February 2013
European Medicines Agency recommends extending the therapeutic indication of Cervarix
On 21 February 2013, the European Medicines Agency Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion recommending a variation to the terms of the marketing authorisation for the medicinal product Cervarix. The marketing authorisation holder for this medicinal product is GlaxoSmithKline Biologicals S.A. Read more here.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment